Cargando…
DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery
Lipid nanoparticle (LNP) technology has become extremely demanding for delivering RNA-products and other drugs. However, there is no platform to manufacture pharmaceutical-grade LNPs with desired particle size from a wide range in continuous mode. We have developed a unique platform to obtain any sp...
Autores principales: | Nag, Kakon, Sarker, Md. Enamul Haq, Kumar, Samir, Khan, Habiba, Chakraborty, Sourav, Islam, Md. Jikrul, Baray, Juwel Chandra, Khan, Maksudur Rahman, Mahmud, Asif, Barman, Uttam, Bhuiya, Eleus Hussain, Mohiuddin, Mohammad, Sultana, Naznin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172984/ https://www.ncbi.nlm.nih.gov/pubmed/35672337 http://dx.doi.org/10.1038/s41598-022-12100-z |
Ejemplares similares
-
An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose
por: Nag, Kakon, et al.
Publicado: (2021) -
A novel knowledge-derived data potentizing method revealed unique liver cancer-associated genetic variants
por: Sultana, Naznin, et al.
Publicado: (2019) -
Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering
por: Nag, Kakon, et al.
Publicado: (2023) -
siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases
por: Kalita, Tutu, et al.
Publicado: (2022) -
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
por: Lutz, Johannes, et al.
Publicado: (2017)